The objective of this study was to determine the immune responses to candidate viral triggers of multiple sclerosis in patients and healthy siblings raised in the same family household. Virus antigen-specific IgG responses to Epstein-Barr virus-derived gene products as well as to human herpersvirus-6, human cytomegalovirus, and measles virus were evaluated in 25 multiple sclerosis patients and compared with 49 healthy full-siblings. IgG responses to the latent Epstein-Barr virus-encoded nuclear antigen-1 (EBNA1) were selectively increased in individuals with multiple sclerosis compared with their unaffected siblings. We conclude that elevated IgG responses towards EBNA1 are associated with the development of multiple sclerosis.
Introduction
Investigating host-pathogen interactions in patients with multiple sclerosis (MS) compared with unaffected siblings who were likely exposed to similar environmental factors during childhood/adolescence provides the opportunity to determine antiviral immune responses specifically associated with the development of MS. Here, we determined antibody responses to ubiquitous viruses previously associated with MS in untreated patients and healthy siblings raised in the same family household.
Patients and methods
Twenty-four untreated patients with a diagnosis of definite MS (21 with relapsing-remitting MS, 2 with primary-progressive MS and 1 with transitional progressive MS), 1 patient with a clinically isolated syndrome, and 49 healthy full-siblings were included in the study. The study was approved by the local ethics committee and all the subjects involved in the study gave written informed consent. A summary of demographic and clinical characteristics of patients and siblings is shown in Table 1 .
Virus antigen-specific IgG responses were assessed using commercially available enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturers' recommendations. The following kits were used: Epstein-Barr nuclear antigen 1 (EBNA1) (p72) IgG for the detection of antibody responses towards the immunogeneic C-terminal domain of EBNA1 (Biotest, Dreieich, Germany), EBV-viral capsid antigen (VCA) (p23/p28) IgG (Diamedix Corporation, Miami, USA), human cytomegalovirus (HCMV) and measles virus (viral lysates) IgG (both from BioMerieux, Marcy-l'Etoile, France), as well as human herpes virus 6 (HHV-6) (viral lysates) IgG (Panbio, Brisbane, Australia). The manufacturer's cut-off value for presence of virus-specific antibodies was used and samples with reactivities below cut-off values were excluded from the comparison. EBV DNA was quantified from peripheral blood mononuclear cells (PBMC) by quantitative real-time polymerase chain reaction (PCR) in triplicates using a TaqMan PCR kit and a Model 7500 Sequence Detector (Applied Biosystems, Foster City, CA, USA) as described previously. 1 
Results
As expected, seroprevalence rates of EBV, HHV-6, HCMV, and measles virus infections were similar in patients and non-affected siblings ( Figure 1A ). However, individuals with MS differed from their siblings in showing markedly increased IgG responses to the C-terminal domain of EBNA1 (p ¼ 0.0007; Mann-Whitney U-test). IgG responses to pooled HHV-6 antigens also tended to be higher in some patients (p ¼ 0.014; Mann-Whitney U-test), but EBNA1 remained the only differentially recognized viral antigen following Bonferroni correction (alpha ¼ 0.01). IgG responses to EBV-encoded lytic viral capsid antigens as well as to pooled HCMV-and measles virus-derived antigens were similar in patients with MS and siblings ( Figure 1A ). Given the almost saturated absorbances for EBNA1-specific IgG reactivities, we re-performed both EBV ELISAs using diluted serum samples (1 : 5) and could reproduce our findings of increased EBNA1-specific IgG responses in MS ( Figure 1B) . To determine whether the increased immune response to EBNA1 correlates with higher viral loads, we additionally quantified levels of cell-bound viral genomes in circulating blood cells by real time PCR using bcl-2 DNA controls. 1 EBV DNA was detectable in 9 out of 15 (60%) patients from whom PBMC were accessible for viral load quantification and in 8 out of 15 (53%) of their healthy siblings. Viral loads did not differ significantly between the two groups (median viral titres per 10 6 PBMC in patients versus siblings: 59.7 versus 96.4, p ¼ 0.9; Mann-Whitney U-test).
Discussion
Although raised within the same family microenvironment, patients with MS differ from their siblings in their increased IgG response to EBNA1, the most consistently recognized EBV-derived CD4+ T cell antigen in healthy virus carriers. High IgG activity to EBNA-1 has been found to be associated with an increased risk to develop MS in several studies with sera collected many years before onset of MS 2-5 and a predominant or selective increase of immune responses to EBNA1 has previously been documented in various independent MS populations. 1, 6, 7 The mechanisms responsible for these changes in EBV-specific immunity are not well understood. Three main scenarios have been proposed. (i) Infection with an MS-specific EBV strain leads to increased or altered immune responses to EBNA1. We consider this possibility unlikely since we assume that patients and siblings included in our study are infected with similar strains of EBV. (ii) Host factors predisposing for MS, such as allelic variants of susceptibility genes, favour the presentation and recognition of a particular viral antigen such as EBNA1. Environmental factors clearly require a permissive genetic trait to trigger MS since studies in twins, siblings and adopted relatives of MS patients found no indication for non-genetic transmissibility of the disease. 8, 9 Full-siblings, as studied here, share only 50% of their genes and we cannot exclude the possibility that genetic factors contribute to increased immune responses to EBNA1. However, it appears unlikely that allelic variants of proteins with general immune functions such as HLA-DR alleles or single nucleotide polymorphisms in IL2RA and IL7RA genes are exclusively responsible for the predominant increase of EBNA1-specific immune responses in MS. 10 (iii) Increased EBNA1-specific IgG responses are maintained by an expanded polyspecific T cell repertoire that recognizes both EBNA1 and MS-associated auto-antigens. In support of this hypothesis, patients with MS show selective expansions of T cells specific for EBNA1 which recognize myelin antigens more frequently than other auto-antigens that are not associated with MS. 6 The finding that cell-associated viral loads are not increased in patients with MS suggests that cross-reactivity to auto-antigens instead of an increased availability of EBNA1 could augment such polyspecific T-cell responses. We conclude that the prominent increase of EBNA1-specific IgG responses is specifically associated with the development of MS and unlikely due to infection with an MS-specific EBV strain acquired within the family microenvironment. Further studies are necessary to elucidate the mechanisms by which altered immune responses to EBNA1 could potentially contribute to the pathobiology of MS.
